Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Tari A. King is the chief of breast surgery at Dana-Farber/ Brigham and Women’s Cancer Center (DF/BWCC), the associate division chief for breast surgery at Brigham and Women’s Hospital (BWH) and the Anne E. Dyson Associate Professor of Surgery at Harvard Medical School. She also serves as the associate chair for multidisciplinary oncology in the Department of Surgery and directs the efforts of the Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Program at BWH. Dr. King received her medical degree from University of Colorado Health Sciences Center and completed a general surgery residency at Ochsner Clinic Foundation Hospital (now Ochsner Medical Center) in New Orleans. Dr. King completed both a surgical research fellowship and a breast surgery clinical fellowship at Memorial Sloan Kettering Cancer Center. Dr. King leads the clinical, research, and educational activities of the breast surgical service while also maintaining an active clinical practice devoted to the diagnosis and surgical treatment of breast cancer. Her clinical and research efforts focus on improving clinical management strategies for women at high risk of developing breast cancer with a special emphasis on lobular carcinoma in situ. She also has an interest in the role of surgery in stage IV breast cancer and through the Translational Breast Cancer Research Consortium (TBCRC) she successfully initiated and completed accrual to a multi-center trial addressing this issue. She has received several awards to support her work on the molecular genetics of lobular carcinoma in situ, including the SSO Clinical Investigator Award in Breast Cancer Research (2008), a Career Catalyst Award (2009), an Investigator Initiated Research Award (2012) and a leadership grant from the Susan G. Komen for the Cure Foundation. She currently serves on the Steering Committee for the TBCRC and the NCI Breast Oncology Local Disease Task Force and is the Vice Chair of the Quality Committee for the SSO.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions